Clinical Trials Logo

Citation(s)

  •   Alpert JE, Franznick DA, Hollander SB, Fava M
    Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder. J Clin Psychiatry. 2004 Aug;65(8):1069-75.
  •   Amsterdam JD, Brunswick DJ, Gibertini M
    Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial. J Psychiatr Res. 2004 May-Jun;38(3):259-65.
  •   Amsterdam JD
    Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 1992 May;16(3):271-80.

PET Whole Body Distribution Studies Using the 5-HT1A Agonist, [11C]CUMI

Details for clinical trial NCT01132872